Podcasts about screening test

brief evaluation to detect unnoticed health problems

  • 45PODCASTS
  • 50EPISODES
  • 11mAVG DURATION
  • 1MONTHLY NEW EPISODE
  • Jan 22, 2024LATEST
screening test

POPULARITY

20172018201920202021202220232024


Best podcasts about screening test

Latest podcast episodes about screening test

Celebrate Kids Podcast with Dr. Kathy
The Importance of Checking In: Tips on Keeping Tabs on Your Child's Mental Health

Celebrate Kids Podcast with Dr. Kathy

Play Episode Listen Later Jan 22, 2024 10:23


In this episode of the Celebrate Kids podcast, Dr. Kathy Koch discusses the importance of mental health in teenagers and young children. You're introduced a new screening test that can help detect early signs of mental health disorders and provide early intervention. Dr. Kathy then highlights the significance of early intervention and shares that around 50 percent of lifetime mental health conditions start at the age of 14. She  acknowledges that mental health is a concern for most parents and encourages creating a rhythm for mental health screenings. In closing, Dr. Kathy gives important tips for parents as they care for their kids' mental health

The Prostate Health Podcast
96: Advancing Precision Medicine: EpiSwitch PSE Prostate Cancer Screening Test with 94% Accuracy – Robert Heaton, MD

The Prostate Health Podcast

Play Episode Listen Later Dec 14, 2023 12:32


Do you know that prostate cancer is the second most prevalent cancer in American men, following skin cancer? A new diagnosis of prostate cancer occurs every two minutes. We are delighted to partner with Oxford Biodynamics for today's episode with Dr. Robert Heaton, who joins us to discuss a ground-breaking new prostate cancer screening test that predicts the risk of prostate cancer with 94% accuracy, using a simple blood test. Dr. Heaton is a board-certified pathologist. He completed his medical training at Georgetown University and then spent the next twenty years in the US Navy. After finishing his residency training in pathology, Dr. Heaton became the Director of Laboratory and Clinical Support Services for the National Naval Medical Center before joining various hospital pathology labs and life sciences companies. He is currently the Laboratory Medical Director for Oxford Biodynamics at their CLIA-certified clinical lab in Maryland, where he oversees the clinical operations of their liquid biopsy blood tests. In today's episode, we dive into the details of the innovative EpiSwitch Prostate Screening test, known as the PSE, designed to confirm the presence of prostate cancer, whether symptoms are present or not. This technological advancement is a game-changer! It empowers urologists by providing a precise tool to assess whether a patient should undergo a biopsy or opt for continued monitoring. Stay tuned to learn how this simple yet powerful tool streamlines the screening process for men struggling with prostate cancer. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation.   Show Highlights: At what age should men start getting checked for prostate cancer?  What the screening for prostate cancer typically entails The importance of establishing a baseline to monitor how PSA changes over time Dr. Heaton dives into the details of the EpiSwitch PSA test How men can access the EpiSwitch PSA test Dr. Heaton discusses the accuracy of the EpiSwitch PSA test What is the expected turnaround time for the EpiSwitch PSC test results? Dr. Heaton explains the role of the Epi Switch PSA test in different scenarios The revolutionary EpiSwitch Prostate Screening test has remarkable accuracy in predicting prostate cancer risk through a simple blood test. It holds immense promise for men battling prostate cancer by providing urologists with a precise diagnostic tool and offering a streamlined approach for patients facing the complexities of prostate cancer. Links: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Oxford BioDynamics: Website LinkedIn  Facebook Twitter: @oxbiodynamics and #OBD Instagram: @oxbiodynamics YouTube: @oxfordbiodynamics PSE: Website LinkedIn Facebook Twitter: (@94percent_com) Instagram: (@get_the_pse)

Knocked Up: The Podcast About Getting Pregnant
Changes to the Cervical Screening Test (aka pap smear)

Knocked Up: The Podcast About Getting Pregnant

Play Episode Listen Later Nov 5, 2023 15:34


Resources: and so much more at https://www.womenshealthmelbourne.com.au/blog Find us on Instagram - @knockeduppodcast Join our community! Follow Women's Health Melbourne on Facebook and Instagram (@womenshealthmelbourne), and follow Dr Raelia Lew on Instagram (@drraelialew). Have a question about women's health? Is there a specific topic you'd like us to cover? Email podcast@womenshealthmelbourne.com.au. We keep all requests anonymous. Women's Health Melbourne is a holistic care precinct, for more information about the work we do click here. Hosts: Dr Raelia Lew and Jordi MorrisonSee omnystudio.com/listener for privacy information.

women screenings cervical pap smear screening test raelia lew
JAMA Editors' Summary: On research in medicine, science, & clinical practice. For physicians, researchers, & clinicians.
ICU Decolonization Strategies, Follow Up of Abnormal Cancer Screening Test Results, Bipolar Disorder Review, and more

JAMA Editors' Summary: On research in medicine, science, & clinical practice. For physicians, researchers, & clinicians.

Play Episode Listen Later Oct 10, 2023 12:08


Editor's Summary by Anne Rentoumis Cappola, MD, ScM, Associate Editor of JAMA, the Journal of the American Medical Association, for the October 10, 2023, issue. Related Content: Audio Highlights

The Bert Show
Should Bert Sign Up For A Cancer Screening Test He Saw On INSTA?!

The Bert Show

Play Episode Listen Later Sep 20, 2023 7:40


Should Bert take the screening test that could possibly, MAYBE tell him if he has a chance of having cancer in the future? What do you think? Learn more about your ad choices. Visit megaphone.fm/adchoices

cancer screenings screening test
SBS NITV Radio
Aunty Jill Gallagher encourages communities to stay healthy and strong with a bowel cancer screening test

SBS NITV Radio

Play Episode Listen Later Aug 4, 2023 7:02


“It is better to be safe than sorry. My call to action for Aboriginal Mob across Australia is: don't be complacent; get the kit when it comes to you; do it and send back… Bowel cancer is one of the easiest cancers to treaty if it is done early.” - Aunty Jill Gallagher.

Highlights from The Pat Kenny Show
Trucheck: New cancer screening test

Highlights from The Pat Kenny Show

Play Episode Listen Later Jun 19, 2023 11:36


Maggie Malone, CEO of Certior Health and Dr Nick Flynn, GP and Chief Medical Officer of Certior Health joined Anton Savage who was filling in for Pat to discuss the new cancer screening test.

ceo gp chief medical officers cancer screenings nick flynn screening test maggie malone
SBS NITV Radio
Indigenous communities encouraged to complete a simple screening test that can save lives

SBS NITV Radio

Play Episode Listen Later May 23, 2023 8:10


A new campaign featuring Waanyi Gangalidda and Erub man Trevor Tim is encouraging Aboriginal and Torres Strait Islander peoples to stay strong and healthy by doing a free bowel cancer screening test every 2 years from the age of 50. “I think it's very important that our people, our mob, do the free test. We're talking about leading the way for our people, we need to close the gap and we need our mob to be living longer,” Trevor Tim.

KCSB
UCSB Researchers Develop a New Antibiotics Screening Test

KCSB

Play Episode Listen Later May 13, 2023 14:56


The gold-standard antibiotic screening test has fundamental issues, but UCSB researchers have developed a new test -- one that's much more accurate. The study's lead author speaks with KCSB's Joyce Chi on why the healthcare industry can't let go of the gold-standard test, and on what the new test means for fighting antibiotic resistance.

SBS Sinhala - SBS සිංහල වැඩසටහන
The must known facts about mammogram breast screening test in Australia - ඔස්ට්‍රේලියාවේදී සිදු කරන මැමෝග්‍රම් පරීක්ෂණය ගැන ඔබ දැන සිටිය යුත

SBS Sinhala - SBS සිංහල වැඩසටහන

Play Episode Listen Later Oct 18, 2022 11:16


Listen to the SBS Sinhala radio interview with Dr.Lakmini Busnayaka from Brisbane explaining about the eligibility criteria for mammogram test in Australia and the must known facts about diagnostic test. - පියයුරු පිළිකා කල් ඇතුව හඳුනාගැනීම සඳහා භාවිතා කරන මැමෝග්‍රම් පරීක්ෂණය පිළිබඳ ඔබ දැන ගත යුතුම වැදගත් තොරතුරු දැන ගන්න මේ ගුවන්විදුලි සාකච්ඡාවට සවන් දෙන්න.

UBC News World
Best Fibromyalgia Screening Test In Allentown, PA For Chronic, Generalized Pain

UBC News World

Play Episode Listen Later Jun 8, 2022 2:27


Avrio Genetics (267-329-9319) in Allentown, PA helps you determine whether you're at risk for fibromyalgia. We've recently launched a new genetic screening test for the condition. Learn more at https://avriogenetics.com (https://avriogenetics.com)

Startup Insider
Mit Cardisiographie frühzeitig Herzerkrankungen erkennen - Cardisio schließt 3,5 Mio. Euro Investition ab

Startup Insider

Play Episode Listen Later Nov 2, 2021 20:50


In unserer Nachmittagsfolge begrüßen wir heute Meik Baumeister, Co-Founder und CEO von Cardisio, und sprechen über die Finanzierungsrunde i.H.v. 3,5 Millionen Euro. Cardisio ist ein Mobile-Health-Tech-Unternehmen, das KI für den - Unternehmensangaben zufolge - weltweit ersten und einzigen nicht-invasiven Screening-Test für die Früherkennung von Herzkrankheiten nutzt. Menschen mit Herzerkrankungen sind in der Regel bis zum Auftreten eines Herzinfarkts symptomfrei. Der Cardisiographie-Test soll Herzkrankheiten frühzeitig erkennen und so eine vorbeugende Behandlung ermöglichen. Und das, bevor es zu einem potenziell tödlichen Herzinfarkt kommt. Die Vorteile einer Cardisiographie ist die einfache Handhabung, die Genauigkeit und die kostengünstige Durchführung. Eine Gruppe privater Investoren hat sich jetzt mit insgesamt 3,5 Millionen Euro an dem Startup beteiligt. Zu den individuellen Geldgebern gehören Jim Davidson, der Mitbegründer von Silver Lake, und Shawn O'Neill, Geschäftsführer bei Silver Lake Waterman. Ergänzt wird die Runde durch mehrere neue und bereits existierende Privatinvestoren aus den USA und Deutschland. Wenn auch Du Dein Lieblingstool bewerten willst, schreibe eine Review auf OMR Reviews. Dafür erhältst du einen 20€ Amazon Gutschein. https://moin.omr.com/insider

What I Know Now - the Suite Set Podcast
E 04 What I Know Now - The Cervical Screening Test

What I Know Now - the Suite Set Podcast

Play Episode Play 22 sec Highlight Listen Later Oct 14, 2021 6:18


I know Podcasts are meant to be about true crime, I know, not paps smears and pregnancy! This topic is too important not to soar up the podcast charts! In today's super-fast episode I talk about the Cervical Screening Test (CST) its importance and the facts about CST and pregnancy.*Spoiler alert - it is safe to have a CST when you're pregnant*The benefits of being on top of CST ( the new form of pap smear) far outweigh the uncomfortable bits.  In the past five years, the way CST are undertaken have changed so CST is a really good topic to add to your list of questions to ask your GP.For information on how a CST works visit herehttps://www.health.gov.au/initiatives-and-programs/national-cervical-screening-program/getting-a-cervical-screening-test/how-cervical-screening-worksSome extra information from The Royal Australian and New Zealand College of Obstetricians and Gynaecologists https://ranzcog.edu.au/womens-health/patient-information-resources/cervical-screening-in-australiaThis episode is fact-checked and supported by www.familyhq.com.au - thanks Liz and Sarah.For more on the suite set, please visit us at https://www.thesuiteset.com/pages/our-gift-to-you

Troy for Breakfast - Triple M Great Southern
Katanning Mum Campaigning For Changes To The WA Infant Screening Test

Troy for Breakfast - Triple M Great Southern

Play Episode Listen Later Jul 15, 2021 7:04


Troy Chats with Katanning Mum Rachel on Changes to The WA Infant Screening See omnystudio.com/listener for privacy information.

SBS Tamil - SBS தமிழ்
Dozens of Australians have been barred from the first repatriation flight from India after failing a screening test. - கோவிட் தொற்று உறுதியானதால் விமானத்தில் திரும்ப ம

SBS Tamil - SBS தமிழ்

Play Episode Listen Later May 14, 2021 6:52


Australian News: 14 May 2021 – Fridat Read by Selvi - ஆஸ்திரேலிய செய்திகள்: 14 மே 2021 வெள்ளிக்கிழமை வாசித்தவர்: செல்வி

SBS Hindi - SBS हिंदी
SBS Hindi News 14 May 2021: Dozens of Australian barred from the first repatriation flight from India after failing a screening test

SBS Hindi - SBS हिंदी

Play Episode Listen Later May 14, 2021 11:09


In this latest SBS Hindi News bulletin: Five commissioners to lead Victoria's Australia-first inquiry into injustices committed against Indigenous people; Conflict in Gaza escalates further; Australia's Indian Premier League contingent could return home as early as this weekend and more.

RNZ: Morning Report
New cervical screening test will save lives, but won't fix everything - Māori health workers

RNZ: Morning Report

Play Episode Listen Later May 9, 2021 3:42


Health workers at the frontline of fighting terrible rates of cervical cancer among Māori say a new, easier test, will save lives but isn't a one-stop fix. The government will introduce a type of swab to test for the HPV virus which causes 99 percent of cervical cancers. Women can do it themselves and it's hoped it will rein in cases, particularly among Māori women, who are two and a half times more likely to die from the disease. Health correspondent Rowan Quinn reports.  

RNZ: Morning Report
New cervical screening test will save lives, but won't fix everything - Māori health workers

RNZ: Morning Report

Play Episode Listen Later May 9, 2021 3:42


Health workers at the frontline of fighting terrible rates of cervical cancer among Māori say a new, easier test, will save lives but isn't a one-stop fix. The government will introduce a type of swab to test for the HPV virus which causes 99 percent of cervical cancers. Women can do it themselves and it's hoped it will rein in cases, particularly among Māori women, who are two and a half times more likely to die from the disease. Health correspondent Rowan Quinn reports.  

RNZ: Morning Report
New cervical screening test vastly better to counterpart - researcher

RNZ: Morning Report

Play Episode Listen Later May 9, 2021 4:13


The director of Te Tātai Hauora o Hine, the Centre for Women's Health Research at Victoria University, wants a less invasive cervical screening test rolled out as soon as possible. The government has announced a $55 million funding boost to make the test available, but not until 2023. Currently there are 400,000 New Zealanders who are not getting regular smear tests.  Susie Ferguson spoke to Te Tātai Hauora o Hine founder Bev Lawton.  

RNZ: Morning Report
New cervical screening test vastly better to counterpart - researcher

RNZ: Morning Report

Play Episode Listen Later May 9, 2021 4:13


The director of Te Tātai Hauora o Hine, the Centre for Women's Health Research at Victoria University, wants a less invasive cervical screening test rolled out as soon as possible. The government has announced a $55 million funding boost to make the test available, but not until 2023. Currently there are 400,000 New Zealanders who are not getting regular smear tests.  Susie Ferguson spoke to Te Tātai Hauora o Hine founder Bev Lawton.  

Your Dog Wants You To Know This!
The Nu.Q Cancer Screening Test: Everything You Need To Know with Co-Creator & Veterinary Oncologist Dr. Heather Robles

Your Dog Wants You To Know This!

Play Episode Listen Later Feb 22, 2021 30:38


We're always looking for easier ways to detect cancer earlier. It gives our patients the opportunity for better prognoses.    Today we're talking about one of the new ways to detect cancer early. It's called the Nu.Q Cancer Screening Test, and it was developed by a joint effort from a company called Volition and Texas A&M College of Veterinary Medicine.   Joining me today is Dr. Heather Robles, who led the research at Texas A&M in order to make this test possible.    Dr. Heather Robles is a board-certified veterinary oncologist and Chief Medical Officer of Volition Veterinary Diagnostics Development. She is also the Professor of Oncology at the Texas A&M College of Veterinary Medicine & Biomedical Sciences, along with the Assistant Department Head of Research and the Dr. Fred A. and Vola N. Palmer Chair in Comparative Oncology.    Join us as we spread the word about this test and answer as many questions as we can in this episode.    Resources Mentioned: Volition Veterinary - Nu.Q Cancer Screening Test  Texas A&M GI Lab - Sample Processing/Collection Information    Full show notes and links mentioned in the episode are available at www.caninecanceracademy.com/podcast-ep-35   Don’t forget to say hello on Instagram @thecaninecaneracademy and on Facebook Canine Cancer Academy

You're Kidding, Right?
Newborn Screening Test | study hard little babies!

You're Kidding, Right?

Play Episode Listen Later Jan 13, 2021 8:26


The Newborn Screening Test is a quick, safe and effective way to identify babies at risk of certain serious conditions. Screening is the only way to identify affected babies early as there may be no signs or symptoms of illness at birth. By the time affected babies show symptoms, their development or health may already be impaired. Early diagnosis allows early treatment or management to prevent or reduce complications. Follow us on Instagram: https://www.instagram.com/yourekiddingright.pod/ and  Facebook: https://www.facebook.com/yourekiddingrightpod-107273607638323/ Our email is yourekiddingrightpod@gmail.com Make sure you hit SUBSCRIBE/FOLLOW so you don’t miss out on any pearls of wisdom and RATE if you can to help other people find us! (This isn’t individual medical advice, please use your own clinical judgement and local guidelines when caring for your patients)

Jonesy & Amanda's JAMcast!

What's the verdict, Jonesy? See omnystudio.com/listener for privacy information.

RNZ: Morning Report
Expert calls for DIY cervical screening test

RNZ: Morning Report

Play Episode Listen Later Aug 5, 2020 6:09


The rollout of a cervical screening test that patients can do themselves has been delayed again, with doctors saying some people will die unnecessarily as a result. The alternative to the current speculum test was meant to be introduced next year - after already being delayed three years. Professor Beverley Lawton is Director of Te Tatai Hauora o Hine, the Centre for Women's Health Research, at Victoria University of Wellington and speaks to Corin Dann.

PaperPlayer biorxiv neuroscience
An online headphone screening test based on dichotic pitch

PaperPlayer biorxiv neuroscience

Play Episode Listen Later Jul 22, 2020


Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.07.21.214395v1?rss=1 Authors: Milne, A. E., Bianco, R., Poole, K. C., Zhao, S., Billig, A. J., Chait, M. E. Abstract: Online experimental platforms can be used as an alternative, or complement, to lab-based research. However, when conducting auditory experiments via online methods, the researcher has limited control over the participants' listening environment. We offer a new method to probe one aspect of that environment, headphone use. Headphones not only provide better control of sound presentation but can also "shield" the listener from background noise. Here we present a rapid (< 3 minute) headphone screening test based on Huggins Pitch (HP), a perceptual phenomenon that can only be detected when stimuli are presented dichotically. We validate this test using a cohort of "Trusted" online participants who completed the test using both headphones and loudspeakers. The same participants also trialled a widely used headphone test (AP test; Woods et al., 2017). We demonstrate that compared to the AP test, the HP test has a higher selectively for headphone users, rendering it as a compelling alternative to the existing screening method. Overall, the new HP test correctly detects 80% of headphone users and has a false positive rate of 20%. Moreover, we demonstrate that there is little overlap between participants who pass both HP and AP tests over loudspeakers. Therefore, combining the two tests can lower the false positive rate to ~7% (but at the expense of an increased false negative rate). This should be useful in situations where headphone use is particularly critical (e.g. dichotic or spatial manipulations). An implementation of the new test is available with JavaScript and through Gorilla (gorilla.sc). Copy rights belong to original authors. Visit the link for more info

21st Century Careers
Astrophysics, Space Science, and ISRO are your career interest??? then you must know about JEST i.e. Joint Entrance Screening Test

21st Century Careers

Play Episode Listen Later Mar 30, 2020 26:49


JEST allow applicants who wish to join premium institutes for natural and life sciences program for Ph.D. and Integrated Ph.D. i.e. MSc + Ph.D. During the last podcast, we got introduced to one such premium institute i.e. Tata Institute of Fundamental Research. So, for the students who wish to choose research and become leading scientists they must know these institutes and the kind of program they offer and their eligibility criteria. So, if your broad interests are Physics, Chemistry, Biology, Mathematics, Neurosciences, computer sciences then you must look at JEST and the participating institutes. Therefore, let me begin by introducing these participating institutes and maybe a little bit more about them. This podcast explore on all the participating institutes and their eligibility criteria. --- Send in a voice message: https://anchor.fm/vijay-sonawane/message

VETgirl Veterinary Continuing Education Podcasts
Is cardiac troponin I accurate as a screening test for the diagnosis of HCM in cats | VETgirl Veterinary Continuing Education Podcasts

VETgirl Veterinary Continuing Education Podcasts

Play Episode Listen Later Oct 28, 2019 11:03


In this VETgirl online veterinary CE podcast, we review whether cardiac troponin I is an accurate screening test for the diagnosis of Hypertrophic Cardiomyopathy (HCM) in cats. Hypertrophic cardiomyopathy is defined as concentric hypertrophy of the left ventricle in the absence of any other identifiable cause, in particular systemic hypertension and hyperthyroidism in cats.

VETgirl Veterinary Continuing Education Podcasts
Is cardiac troponin I accurate as a screening test for the diagnosis of HCM in cats | VETgirl Veterinary Continuing Education Podcasts

VETgirl Veterinary Continuing Education Podcasts

Play Episode Listen Later Oct 28, 2019 11:03


In this VETgirl online veterinary CE podcast, we review whether cardiac troponin I is an accurate screening test for the diagnosis of Hypertrophic Cardiomyopathy (HCM) in cats. Hypertrophic cardiomyopathy is defined as concentric hypertrophy of the left ventricle in the absence of any other identifiable cause, in particular systemic hypertension and hyperthyroidism in cats.

Hope Breakfast with Sam & Duncan
SBS News Reader Anton Urges Aussies to Take the Bowel Screening Test; It Saved His Life

Hope Breakfast with Sam & Duncan

Play Episode Listen Later Aug 20, 2019 6:28


Motherhood Channel (Audio)
Genetic Testing During Pregnancy

Motherhood Channel (Audio)

Play Episode Listen Later Jul 30, 2019 4:35


You have the option to screen for a number of genetic disorders in pregnancy. How are these tests performed and what can be discovered? Dr. Julia Cormano explains the difference between screening and diagnostic testing, what can be learned from a blood test, as well what to expect from chorionic villus sampling and amniocentesis. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 33874]

pregnancy genetics cvs women's health down syndrome genetic testing trisomy diagnostic tests medicine show id cell free screening test amniocentesis pregnancy and prenatal care julia cormano series motherhood channel health
UC San Diego (Audio)
Genetic Testing During Pregnancy

UC San Diego (Audio)

Play Episode Listen Later Jul 30, 2019 4:35


You have the option to screen for a number of genetic disorders in pregnancy. How are these tests performed and what can be discovered? Dr. Julia Cormano explains the difference between screening and diagnostic testing, what can be learned from a blood test, as well what to expect from chorionic villus sampling and amniocentesis. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 33874]

pregnancy genetics cvs women's health down syndrome genetic testing trisomy diagnostic tests medicine show id cell free screening test amniocentesis pregnancy and prenatal care julia cormano series motherhood channel health
Genetics (Video)
Genetic Testing During Pregnancy

Genetics (Video)

Play Episode Listen Later Jul 30, 2019 4:35


You have the option to screen for a number of genetic disorders in pregnancy. How are these tests performed and what can be discovered? Dr. Julia Cormano explains the difference between screening and diagnostic testing, what can be learned from a blood test, as well what to expect from chorionic villus sampling and amniocentesis. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 33874]

pregnancy genetics cvs women's health down syndrome genetic testing trisomy diagnostic tests medicine show id cell free screening test amniocentesis pregnancy and prenatal care julia cormano series motherhood channel health
Genetics (Audio)
Genetic Testing During Pregnancy

Genetics (Audio)

Play Episode Listen Later Jul 30, 2019 4:35


You have the option to screen for a number of genetic disorders in pregnancy. How are these tests performed and what can be discovered? Dr. Julia Cormano explains the difference between screening and diagnostic testing, what can be learned from a blood test, as well what to expect from chorionic villus sampling and amniocentesis. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 33874]

pregnancy genetics cvs women's health down syndrome genetic testing trisomy diagnostic tests medicine show id cell free screening test amniocentesis pregnancy and prenatal care julia cormano series motherhood channel health
Motherhood Channel (Video)
Genetic Testing During Pregnancy

Motherhood Channel (Video)

Play Episode Listen Later Jul 30, 2019 4:35


You have the option to screen for a number of genetic disorders in pregnancy. How are these tests performed and what can be discovered? Dr. Julia Cormano explains the difference between screening and diagnostic testing, what can be learned from a blood test, as well what to expect from chorionic villus sampling and amniocentesis. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 33874]

pregnancy genetics cvs women's health down syndrome genetic testing trisomy diagnostic tests medicine show id cell free screening test amniocentesis pregnancy and prenatal care julia cormano series motherhood channel health
Women's Health (Video)
Genetic Testing During Pregnancy

Women's Health (Video)

Play Episode Listen Later Jul 30, 2019 4:35


You have the option to screen for a number of genetic disorders in pregnancy. How are these tests performed and what can be discovered? Dr. Julia Cormano explains the difference between screening and diagnostic testing, what can be learned from a blood test, as well what to expect from chorionic villus sampling and amniocentesis. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 33874]

pregnancy genetics cvs women's health down syndrome genetic testing trisomy diagnostic tests medicine show id cell free screening test amniocentesis pregnancy and prenatal care julia cormano series motherhood channel health
UC San Diego (Video)
Genetic Testing During Pregnancy

UC San Diego (Video)

Play Episode Listen Later Jul 30, 2019 4:35


You have the option to screen for a number of genetic disorders in pregnancy. How are these tests performed and what can be discovered? Dr. Julia Cormano explains the difference between screening and diagnostic testing, what can be learned from a blood test, as well what to expect from chorionic villus sampling and amniocentesis. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 33874]

pregnancy genetics cvs women's health down syndrome genetic testing trisomy diagnostic tests medicine show id cell free screening test amniocentesis pregnancy and prenatal care julia cormano series motherhood channel health
Women's Health (Audio)
Genetic Testing During Pregnancy

Women's Health (Audio)

Play Episode Listen Later Jul 30, 2019 4:35


You have the option to screen for a number of genetic disorders in pregnancy. How are these tests performed and what can be discovered? Dr. Julia Cormano explains the difference between screening and diagnostic testing, what can be learned from a blood test, as well what to expect from chorionic villus sampling and amniocentesis. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 33874]

pregnancy genetics cvs women's health down syndrome genetic testing trisomy diagnostic tests medicine show id cell free screening test amniocentesis pregnancy and prenatal care julia cormano series motherhood channel health
SBS Hmong - SBS Hmong
Cervical cancer screening test - Mus sim seb puas tau cov kab mob cancer tsev me nyuam

SBS Hmong - SBS Hmong

Play Episode Listen Later Jul 11, 2019 11:55


Don't let embarrassment from doing a cervical cancer screening test kill you. - Txhob cia txoj kev txaj muag ua rau koj tas sim neej vim tsis xav mus sim seb puas puas yog koj mob kab mob cancer tsev me nyuam!

A Canadian Celiac Podcast
Ep 67 New Study on a Screening Test for Celiac Disease in Children

A Canadian Celiac Podcast

Play Episode Listen Later Apr 24, 2019 39:53


  I was intrigued to speak with Dr. Herbert Brill of William Osler Health System regarding the study he did with other health care professionals on the efficacy of the DGP blood test with children referred for further consultation in screening for celiac disease.  The study focussed on children with a negative TTG test and a positive DGP test.  The study concluded the test was not useful in screening children for celiac disease in the general population.  You can find an article about the study on the William Osler Health System website or at the following link – http://bit.ly/DGPTestStudy This study was brought to my attention by a post from Ellen Bayens of The Celiac Scene.  You can subscribe to her newsletter at www.theceliacscene.com.  Thanks Ellen! Sue's Websites and Social Media – Podcast https://acanadianceliacpodcast.libsyn.com Podcast Blog – https://www.acanadianceliacblog.com Facebook - @acanadianceliacpodcast Twitter – CeliacPodcastCA Email – acdnceliacpodcast@gmail.com Baking Website – https://www.suesglutenfreebaking.com Instagram - @suesgfbaking YouTube - https://www.youtube.com/playlist?list=PLUVGfpD4eJwwSc_YjkGagza06yYe3ApzL      (search Sues Gluten Free Baking) Email – sue@suesglutenfreebaking.com Other Podcast – Gluten Free Weigh In – https://glutenfreeweighin.libsyn.com

A Canadian Celiac Podcast
Ep 67 New Study on a Screening Test for Celiac Disease in Children

A Canadian Celiac Podcast

Play Episode Listen Later Apr 24, 2019 39:53


  I was intrigued to speak with Dr. Herbert Brill of William Osler Health System regarding the study he did with other health care professionals on the efficacy of the DGP blood test with children referred for further consultation in screening for celiac disease.  The study focussed on children with a negative TTG test and a positive DGP test.  The study concluded the test was not useful in screening children for celiac disease in the general population.  You can find an article about the study on the William Osler Health System website or at the following link – http://bit.ly/DGPTestStudy This study was brought to my attention by a post from Ellen Bayens of The Celiac Scene.  You can subscribe to her newsletter at www.theceliacscene.com.  Thanks Ellen! Sue's Websites and Social Media – Podcast https://acanadianceliacpodcast.libsyn.com Podcast Blog – https://www.acanadianceliacblog.com Facebook - @acanadianceliacpodcast Twitter – CeliacPodcastCA Email – acdnceliacpodcast@gmail.com Baking Website – https://www.suesglutenfreebaking.com Instagram - @suesgfbaking YouTube - https://www.youtube.com/playlist?list=PLUVGfpD4eJwwSc_YjkGagza06yYe3ApzL      (search Sues Gluten Free Baking) Email – sue@suesglutenfreebaking.com Other Podcast – Gluten Free Weigh In – https://glutenfreeweighin.libsyn.com

POP
POP - s01e19 - Futuro Anteriore - Intervista a Margherita Mauro e Giulio Costa

POP

Play Episode Listen Later Feb 21, 2019 43:30


Questa sera a POP si parla di Futuro Anteriore, spettacolo di Produzione Ferrara Off, con la drammaturga Margherita Mauro e il regista Giulio Costa. fra gli interpreti anche Matilde, per uno spettacolo sul futuro della terza età che sarà in prima Nazionale questo weekend a Ferrara Off http://www.ferraraoff.it/futuro-anteriore/

Dragoman Transcreation
How to build a screening test for interpreting students?

Dragoman Transcreation

Play Episode Listen Later Oct 1, 2018 3:21


There is no golden standard on preparing a screening test for interpreting students. You are supposed to find your own way. In this article I would like to share my approach. Screening test is a must: For one, not every student can become a simultaneous interpreter. Giving false hopes to young minds will only increase their desperation before your realize it is too late. Second, interpreter trainers are usually professional interpreters and they do not have the time and energy needed […]

giving students screenings interpreting translation studies screening test
Health Files With Dr. Miles
Episode 1 - The Chocolate Debut - Chocolate & Diabetes, Colonoscopy

Health Files With Dr. Miles

Play Episode Listen Later Aug 13, 2017 22:15


In this episode we talk about the health effects of Chocolate, Diabetes, a Screening Test and spin the Wheel of Medicine. We hope you join us as we dive deep into medicine so you don't have to. We present the best studies and research in easy to understand and entertaining ways. We gladly accept show topics and ideas from our listeners.

Veterinary ECC Small Talk
Canine Hypoadrenocorticism (Addison's Disease): 10 Talking Points

Veterinary ECC Small Talk

Play Episode Listen Later Feb 13, 2015 29:23


Dogs (and cats) having a crisis as a result of hypoadrenocorticism (Addisonian crisis) can be in a life-threatening state and this represents one of the true small animal emergencies. Stabilisation of these patients starts with appropriately aggressive intravenous fluid therapy as the first priority and treatment for clinically significant hyperkalaemia and hypoglycaemia may also be needed very early on. Intravenous glucocorticoids are typically then required to continue stabilisation. In this episode I discuss ten talking points relating to canine hypoadrenocorticism, namely: “The Great Pretender” Likely Genetic Basis Aldosterone may be low in ‘atypical’ cases Hypoglycaemia may be severe Bradycardia is not always present and not just due to hyperkalaemia ACTH stimulation test provides definitive diagnosis Single resting plasma cortisol may be useful for screening – but limited role in emergencies? Intravenous fluid therapy Client communication and education Prognosis is good with appropriate management – yey!   Click Here For Your FREE Copy of a Transcript of This Episode   PAPERS that helped inspire some of the content for this episode are: Baumstark ME, Sieber-Ruckstuhl NS, Mϋller C, et al. Evaluation of Aldosterone Concentrations in Dogs with Hypoadrenocorticism. J Vet Intern Med 2014; 28:154–159. (Open access online) Boag AM, Catchpole B. A Review of the Genetics of Hypoadrenocorticism. Topics in Companion Animal Medicine 2015 (Accepted manuscript pending publication). Bovens C, Tennant K, Reeve J, Murphy KF. Basal Serum Cortisol Concentration as a Screening Test for Hypoadrenocorticism in Dogs. J Vet Intern Med 2014; 28:1541–1545. (Open access online) Lennon EM, Boyle TE, Hutchins RG, et al. Use of basal serum or plasma cortisol concentrations to rule out a diagnosis  of hypoadrenocorticism in dogs:  123 cases (2000–2005). J Am Vet Med Assoc 2007; 231:413–416. (Abstract)

Tierärztliche Fakultät - Digitale Hochschulschriften der LMU - Teil 06/07
Evaluation eines ultrasensitiven Troponin-I assays als Screening-Test und zur Unterscheidung verschiedener Schweregrade der felinen hypertrophen Kardiomyopathie

Tierärztliche Fakultät - Digitale Hochschulschriften der LMU - Teil 06/07

Play Episode Listen Later Jul 21, 2012


Sat, 21 Jul 2012 12:00:00 +0100 https://edoc.ub.uni-muenchen.de/17336/ https://edoc.ub.uni-muenchen.de/17336/1/Roos_Anja.pdf Roos, Anja Alexandra

evaluation screenings roos unterscheidung assays troponin screening test ddc:500 kardiomyopathie schweregrade ddc:590
PorkPod
New Screening Test for Antibiotic Residue

PorkPod

Play Episode Listen Later Sep 6, 2011 11:02


New Screening Test for Antibiotic Residue

Audio Medica News - Medical News Interviews
GENERAL MEDICINE: Visual Cervix Cancer Screening Test: Cheap and Effective in the Developing World

Audio Medica News - Medical News Interviews

Play Episode Listen Later Aug 8, 2007 5:08


Audio Journal of Medicine, August 8th 2007 Visual Cervix Cancer Screening Test: Cheap and Effective in the Developing World REFERENCE: Lancet 2007;370:398-406 RENGASWAMY SANKARANARAYANAN, International Agency for Research on Cancer, Lyon An inexpensive visual cervix cancer-screening test has proved its worth in India according to a publication in the Lancet. Inspecting the cervix visually after applying 4% acetic acid can reduce the incidence and mortality from cervical cancer in developing countries. Nicola Solomon interviewed Rengaswamy Sankaranarayanan.

Medizinische Fakultät - Digitale Hochschulschriften der LMU - Teil 07/19
Korrelation peripherer Farbkontrast-Schwellenwerte mit den stereometrischen Parametern des Heidelberg-Retina- Tomographen

Medizinische Fakultät - Digitale Hochschulschriften der LMU - Teil 07/19

Play Episode Listen Later Jun 28, 2007


Hintergrund: Die konventionelle Weiss-auf-Weiss-Perimetrie zählt zum Goldstandard der Glaukom-Diagnostik. Der Verlust achromatischer Kontrastempfindlichkeit ist aber als sensorischer Ausfall ein Spätsymptom und markiert den Beginn einer lokalen Erblindung. In diversen Studien konnte nachgewiesen werden, dass ein Verlust an chromatischer Kontrastempfindlichkeit im kurzwelligen Bereich des Farbspektrums perimetrischen Gesichtsfelddefekten vorausgehen kann. Eine quantitative Bestimmung peripherer Farbkontrastempfindlichkeit erlaubt der Arden-Computergraphik-Farbtest. Ziel dieser Querschnittsstudie war zum einen, Unterschiede in der peripheren Farbkontrast-Sensitivität zwischen einer größeren Gruppe von Glaukom-Patienten (n=50), sogenannten präperimetrischen Diagnosegruppen (Patienten mit okulärer Hypertension, Patienten mit V.a. Glaukom, n=41) und augengesunden Patienten (n=19) zu finden, und zum anderen die Bestimmung von Zusammenhängen zwischen peripheren Farbkontrast-Verlusten im kurzwelligem Bereich (Tritanachse) und zu diesem Zeitpunkt gegebenenfalls bestehenden Pathologien der Papillenmorphologie. Hierfür wurde sowohl der Mittelwert der Farbkontrastempfindlichkeit der einzelnen Quadranten, als auch die Farbkontrastempfindlichkeit eines einzelnen Quadranten (hier „Field Low Left“) mit den entsprechenden HRT II-Parametern (global oder ein einzelner Sektor) korreliert. Patienten und Methodik: Insgesamt wurden 110 Patienten in die Studie miteingeschlossen, und in die Diagnosegruppen „Glaukom“ (n=50), „V.a. Glaukom“ (n=26), „OCH“ (n=13) und „Augengesund“ (n=21) eingeteilt. Bei allen Patienten wurde eine Messung mit dem HRT II zur Erhebung quantitativer Papillen-Mekmale, und der Arden-Computergraphik-Farbtest durchgeführt. Darüber hinaus erfolgte jeweils eine Gesichtsfelduntersuchung, eine Visusbestimmung, eine allgemeine Anamnese, eine ausführliche Medikamentenanamnese und die Bestimmung der im bisherigen Krankheitsverlauf maximalen Tensiowerte. Die Papillenmorphologie wurde anhand qualitativer Merkmale von einem erfahrenen Untersucher in folgende Gruppen eingeteilt: „glaukomatöser Papillenbefund“, „grenzwertiger Papillenbefund“ und „unauffälliger Papillenbefund“. Nichtparametrische Tests: Im Kruskall-Wallis-Test zeigten die Variablen „Field mean“ und „Field LowL“ einen signifkanten Unterschied (p=0,039 bzw. p=0,023) zwischen den Diagnosegruppen. Im Mann-Whitney-Test erfüllen „Field LowL“-Werte die Kriterien einer Zusammenfassung 66 Signifikanz-Adjustierung und unterscheiden sich zwischen den Diagnosgruppen „Glaukom“ und „Augengesund“ statistisch signifkant (p=0,006). Ergebnisse der bivariaten Korrelation: Sowohl im Gesamtkollektiv, als auch in der Diagnosegruppe „Glaukom“ zeigte der Farbkontrast-Schwellenwert des unteren linken Quadranten („Field LowL“) im Unterschied zum Mittelwert der Farbkontrast-Schwellenwerte der Einzel-Quadranten („Field mean“) die stärkeren und häüfigeren Zusammenhänge zur Papillenmorphologie. In der Gruppe „Glaukom“ zeigte „Field LowL“ statistisch signifikante Zusammenhänge zu den meisten stereometrischen Parametern des HRT II: „cup area“ (r=0,547, p=0,000), „rim area“ (r=0,456, p=0,001), „cup/disc area ratio“ (r=0,525, p=0,000), „rim/disc area ratio“ (r=0,525, p=0,000), „cup volume“ (0,453, p=0,001), „rim volume“ (r=0,409, p=0,003), „height variation contour (r=0,38, p=0,006), „cup shape measure“ (r=0,345, p=0,012), „mean RNFL thickness“ (r=0,404, p=0,004) und „RNFL cross sectional area“ (r=0,381, p=0,006). In den präperimetrischen Diagnosegruppen „V.a. Glaukom“ und „OCH“ konnte nur in der „OCH“-Gruppe ein statistisch hochsignifikanter Zusammenhang (r=0,764, p=0,001) zwischen „Field LowL“ und dem stereometrischen Paramter „height variation contour“ gefunden werden. Ergebnisse der partiellen Korrelation: Bei Konstanthalten des Einflusses der Variable „age“ in der Glaukom-Gruppe zeigt „Field mean“ einen moderaten, statistisch signifikanten Zusammenhang zu den HRT-II-Parametern „height variation contour“ (r=0,348, p=0,008) und „CLM temporal-inferior“ (r=0,371, p=0,005). Bei Herauspartialisieren der Variable „disc area“ konnten alle in der bivariaten Korrelation gefundenen Zusammenhänge beibehalten werden. Bei Konstanthalten des Einflusses der mittleren Defekttiefe der Gesichtsfelduntersuchung („MD in dB“) zeigten sich keine statistisch signifikanten Zusammenhänge. Im Unterschied dazu zeigte der Quadranten-Schwellenwert „Field LowL“ in der Glaukom-Gruppe sowohl bei Konstanthalten des Einflusses des Alters, als auch der Papillengröße, als auch der mittleren Defekttiefe der Gesichtsfeld-Untersuchung statistisch signifikante Zusammenhänge zu allen auch in der Pearson-Korrelation gefundenen stereometrischen HRT-II-Parametern, wobei die Zusammenhangs-Stärke bei Herauspartialisieren von „disc area“ und „MD in dB“ schwächer ausfiel als in der bivariaten Korrelation; bezüglich der Kontrollvariable „MD in dB“ sind es: „cup area“ (r=0,457, p=0,001), „rim area“ (r=0,290, p=0,033), „cup/disc area ratio“ (r=0,419, p=0,003), „rim/disc area ratio“ (r=0,419, p=0,003), „cup volume“ (0,333, p=0,017), „rim volume“ (r=0,319, p=0,021), „height variation contour (r=0,304, p=0,027), „cup shape measure“ (r=0,260, Zusammenfassung 67 p=0,05), „mean RNFL thickness“ (r=0,411, p=0,004) und „RNFL cross sectional area“ (r=0,354, p=0,012). Der in der bivariaten Korrelation in der „OCH“-Gruppe gefundene, starke Zusammenhang zwischen „Field LowL“ und dem stereometrischen Paramter „height variation contour“ zeigte sich auch bei Herauspartialisieren des Alters und der mittlerern Defekttiefe der Gesichtsfeld-Untersuchung: r=0,686, p=0,01 bzw. r=0,794, p=0,002, jedoch nicht bei Herauspartialisieren der Variablen „disc area“ (r=0,001, p=0,499). Der überwiegende Teil der in den präperimetrischen Diagnosegruppen gefundenen Zusammenhänge zeigte sich jedoch statistisch nicht signifikant. Ergebnisse der Regressionsanalyse: Sowohl nichtstereometrische Parameter wie Alter, Augeninnendruck und Ergebnisse der Gesichtsfelduntersuchung, als auch die stereometrischen Parameter des Heidelberg-Retina-Tomographen-II zeigen einen statistisch signifikanten Einfluss auf die Ergebnisse des Computergraphik-Farbtests. Während der Einfluss von nichtstereometrischen Parametern einen stärkeren Einfluss auf die Variable „Field mean“ als auf die Variable „Field LowL“ aufweist (r2=0,445, p=0,000 versus r2=0,359, p=0,001), verhält es sich mit den stereometrischen HRT-II-Parametern umgekehrt: Sie zeigen den stärkeren Einfluss auf die Variable „Field LowL“ (r2=0,603, p=0,000 versus r2=0,188, p=0,048). Schlussfolgerung: Die Diagnose „Glaukom“ setzt sich aus den Ergebnissen unterschiedlicher Untersuchungen zusammen. Zu den Eckpfeilern der Glaukom-Diagnostik zählen Papillenveränderungen, erhöhter Augeninnendruck, Gesichtsfelddefekte und schließlich das Alter und die Familienanamnese eines Patienten. In den letzten Jahrzehnten hielt vor allem die qualitative Messung der Papillenmorphologie und umgebender Netzhaut-Strukturen (HRT, OCT, GDX, u.a.) Einzug in die Glaukom-Diagnostik. Gemeinsam mit psychophysikalischen Tests, die Gesichtfelddefekte nachweislich vor dem Verlust an Kontrastempfindlichkeit in der Weiss-auf-Weiss-Perimetrie aufzeigen, erweitert und ergänzt sie die klassische Glaukom-Diagnostik. In dieser Arbeit konnte zunächst bestätigt werden, dass sich die Ergebnisse des Arden-Computergraphik-Farbtests bei einer erstmals großen Gruppe von Glaukom-Patienten signifikant von den Ergebnissen der Kontrollgruppe augengesunder Patienten unterscheiden. Im weiteren konnte erstmals gezeigt werden, dass auch unter Berücksichtigung des Alters und der Ergebnisse der Gesichtsfelduntersuchung ein überwiegend hochsignifikanter Zusammenhang zwischen einem funktionellen Test (Arden- Computergraphik-Farbtest) und einem modernen, rein morphologischen Test (HRT II) bei Glaukompatienten besteht. Die Einzel-Quadranten-Analyse (hier der funktionell linke untere Zusammenfassung 68 Quadrant) zeigte hier die stärksten Zusammanhänge zu den Parametern „cup area“, „rim area“, cup/disc area ratio“ und „rim/disc area ratio“ und ist dem Mittelwert der Schwellenwerte aller Quadranten überlegen. Die statistisch signifikanten Veränderungen entsprechen dem temporal-superioren Bereich der Papille, in dem in frühen und in mäßig fortgeschrittenen Glaukom-Stadien erste Verluste des neuroretinalen Randsaums zu beschrieben sind (Tuulonen A & Airaksinen PJ, 1991, Jonas JB et al., 1993). Dem Arden-Computergraphik-Farbtest kommt somit ein hoher Stellenwert in der Glaukomdiagnostik zu. Die Kombination von Funktion und Morphologie erhöht die Validität in der Glaukomdiagnostik; eine Eignung als Screening-Test, der zwischen präperimetrischen Diagnosegruppen unterscheidet, konnte allerdings nicht bestätigt werden.

The Shrink Is  In-  The  Podcast Voice of Psychology
A Simple Screening Test for Autism-Maybe?

The Shrink Is In- The Podcast Voice of Psychology

Play Episode Listen Later Apr 9, 2007 5:48


Today's podcast presents a review of a psychological study of a simple screening test for Autism that can be used with infants of 12 months of age. The study presents correlational data that can be helpful for pediatricians and parents to use with infants at 12 months of age. The test is simple and harmless, but it cannot be used to defintely prove whether a child has Autism.

Medizinische Fakultät - Digitale Hochschulschriften der LMU - Teil 04/19
GSD Typ II und Typ IV: Biochemische und molekulargenetische Analyse bei Patienten mit Mangel an saurer α-Glukosidase bzw. mit Branchingenzymmangel

Medizinische Fakultät - Digitale Hochschulschriften der LMU - Teil 04/19

Play Episode Listen Later Jun 9, 2005


Die Glykogen-Speicherkrankheit (GSD) ist eine seltene Stoffwechselerkrankung, die in verschiedenen Ausprägungen (Typen) vorkommt. Im ersten Teil der Arbeit wird durch Messung der Enzymaktivität von saurer α-Glukosidase und der Enzymaktivität des Branchingenzyms ein Screening-Test durchgeführt. Im zweiten Teil wird durch Genanalyse als diagnostische Methode die Erklärung der Erkrankung auf molekulargenetischer Ebene erforscht, um den Zusammenhang zwischen dem Geno- und Phenotyp zu verstehen.

arbeit analyse erkl zusammenhang methode ebene mangel geno typen erkrankung auspr messung screening test bei patienten ddc:600 enzymaktivit typ ii genanalyse